Next Generation Sequencing Market Growth Analysis on Top Key Players Illumina, Inc., Thermo Fisher Scientific, Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation

Next Generation Sequencing Market was valued at $3,567 million in 2015, and is expected to reach $12,801 million in 2022, supported by a CAGR of 19.9% during the forecast period 2014 to 2022. NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing. NGS minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2048?utm_source=OPR

NGS is also known as high-throughput and massive parallelization sequencing technology. In the NGS process, genetic material is extracted, fragmented, and linked to adapters and primers for the amplification reaction (PCR) for library construction. Sequencing of the fragmented genetic material is executed, NGS furnishes a massive set of sequence data in a very small duration. This data is further interpreted and analyzed by clinicians, researchers, scientists and others through clinical, agricultural, forensic, and other applications For instance, NGS has helped researchers identify desirable traits, which have led to resilient and productive livestock and crops. The increase in usage and application of NGS is expected to boost the market growth.

The major factors that drive the global NGS market are rise in technological advancements in NGS, growth in collaborations & partnerships, and increase in genome mapping programs throughout the world. In addition, rise in investment in R&D increases the demand for NGS and thereby provides lucrative opportunities for market growth. However, accuracy & standardization concerns and ethical & legal limitations associated with NGS restrain the market growth.

The consumables product segment occupies the greatest share in the NGS product market owing to their sheer usage and need throughout the sample preparation, library construction, and other pre-requisite steps of NGS. Sequencing by synthesis technology is anticipated to dominate the global NGS market as most of the widely used NGS platforms utilize this technology in NGS methods. It accounted for over half of the total share in 2015.

Biomarkers and cancer is currently dominating the application segment and is expected to grow at a CAGR of 19.8%. NGS possesses the potential to recognize a broad spectrum of genetic differences and supplement the generation of potent biomarkers in medicine and disease diagnostics. In addition, sequencing time, protocol length, declining cost of NGS are factors that make NGS an ideal tool for biomarker discovery.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/2048?utm_source=OPR

In 2015, Asia-Pacific and LAMEA collectively accounted for two-sevenths of the global NGS market, and are expected to continue this trend due to rise in awareness regarding NGS technologies in China, India, and other developing economies. Various governmental and non-governmental organizations initiate genome mapping programs that supplement the growth of NGS market. In addition, increase in investments in R&D by public and private sectors is also expected to boost the market growth.

The major companies profiled in the report include Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Perkinelmer, Inc. Genomatix GmbH, and PierianDx

Table Of Content


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Technological advancements in NGS
3.5.1.2. Surge in applications of NGS
3.5.1.3. Increase in partnerships and collaborations
3.5.1.4. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Standardization concerns over NGS based diagnostics
3.5.2.2. Lack of skilled professionals
3.5.2.3. Ethical and legal limitations

3.5.3. Opportunities

3.5.3.1. Lucrative opportunities in emerging markets
3.5.3.2. Cloud computing: potential data management service

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/next-generation-sequencing-market.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.